Uploaded June 2026 | Updated September 2026, 2 weeks ago

---

At Rush, donor support is helping turn possibility into reality. Dr. Deborah Hall shares the story behind the first gene therapy delivered to humans for Huntington’s disease — a groundbreaking milestone made possible through innovation and collaboration. As one of only six sites in the nation leading this clinical trial, Rush is advancing a new future for patients facing complex neurological diseases.

To partner with us and help advance the treatment of Huntington's Disease, visit: rushgiving.com/supporthuntingtonsprogram